Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human Macrophages

Tuberculosis (TB) is one of the top 10 leading causes of death worldwide. The recombinant BCG strain expressing the genetically detoxified A subunit of the thermolabile toxin from Escherichia coli (LTAK63) adjuvant (rBCG-LTAK63) has previously been shown to confer superior protection and immunogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Carina C., Walburg, Kimberley V., van Veen, Suzanne, Wilson, Louis G., Trufen, Carlos E. M., Nascimento, Ivan P., Ottenhoff, Tom H. M., Leite, Luciana C. C., Haks, Mariëlle C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227035/
https://www.ncbi.nlm.nih.gov/pubmed/35746439
http://dx.doi.org/10.3390/vaccines10060831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227035/
https://www.ncbi.nlm.nih.gov/pubmed/35746439
http://dx.doi.org/10.3390/vaccines10060831

Ejemplares similares